Publication:
Back to the future: Antibody-based strategies for the treatment of infectious diseases

Simple item page
dc.contributor.authorAkdiş, Cezmi
dc.contributor.buuauthorOral, Haluk Barbaros
dc.contributor.buuauthorÖzakın, C.
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentİmmunoloji Ana Bilim Dalı
dc.contributor.departmentMikrobiyoloji Bölümü
dc.contributor.scopusid7004498001
dc.contributor.scopusid57200678942
dc.date.accessioned2021-11-30T10:35:41Z
dc.date.available2021-11-30T10:35:41Z
dc.date.issued2002-07
dc.description.abstractBefore antibiotics, sera from immune animals and humans were used to treat a variety of infectious diseases, often with successful results. After the discovery of antimicrobial agents, serum therapy for bacterial infections was rapidly forsaken. In the last two decades, problems with treatment of newly emerged, re-emerged, or persistent infectious diseases necessitated researchers to develop new and/or improved antibody-based therapeutic approaches. This article reviews some information on the use of antibodies for the treatment of infectious diseases, with special reference to the most seminal discoveries and current advances as well as available treatment approaches in this field.
dc.identifier.citationOral, H. B. vd. (2002). "Back to the future: Antibody-based strategies for the treatment of infectious diseases". Molecular Biotechnology, 21(3), 225-236.
dc.identifier.endpage239
dc.identifier.issn1073-6085
dc.identifier.issue3
dc.identifier.pubmed12102547
dc.identifier.scopus2-s2.0-0036634582
dc.identifier.startpage225
dc.identifier.urihttps://doi.org/10.1385/MB:21:3:225
dc.identifier.urihttps://link.springer.com/article/10.1385%2FMB%3A21%3A3%3A225
dc.identifier.urihttp://hdl.handle.net/11452/22886
dc.identifier.volume21
dc.identifier.wos000176468500004
dc.indexed.scopusScopus
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherHumana Press
dc.relation.collaborationYurt dışı
dc.relation.journalMolecular Biotechnology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectImmunoglobulin
dc.subjectSeptic shock
dc.subjectAntibody therapy
dc.subjectInfectious diseases
dc.subjectHuman-immunodeficiency-virus
dc.subjectTumor-necrosis-factor
dc.subjectHuman monoclonal-antibody
dc.subjectPlacebo-controlled trial
dc.subjectIntravenous immunoglobulin therapy
dc.subjectBone-marrow transplantation
dc.subjectGram-negative bacteremia
dc.subjectB immune globulin
dc.subjectLipid-a domain
dc.subjectBiochemistry & molecular biology
dc.subjectBiotechnology & applied microbiology
dc.subjectAnimalia
dc.subjectBacteria (microorganisms)
dc.subjectCytomegalovirus
dc.subject.emtreeHepatitis B vaccine
dc.subject.emtreeBacterium antibody
dc.subject.emtreeMonoclonal antibody
dc.subject.emtreeVirus antibody
dc.subject.emtreeAntibody
dc.subject.emtreeCentoxin
dc.subject.emtreeChickenpox vaccine
dc.subject.emtreeCytomegalovirus vaccine
dc.subject.emtreeDiphtheria antibody
dc.subject.emtreeHepatitis A vaccine
dc.subject.emtreeImmunoglobulin
dc.subject.emtreeThromboembolism
dc.subject.emtreeInterleukin 6 antibody
dc.subject.emtreeDrug cost
dc.subject.emtreeMeasles vaccine
dc.subject.emtreeImmunotherapy
dc.subject.emtreeMumps Vaccine
dc.subject.emtreeNeutralizing antibody
dc.subject.emtreeBacterial infection
dc.subject.emtreeRabies vaccine
dc.subject.emtreeAseptic meningitis
dc.subject.emtreeRubella vaccine
dc.subject.emtreeAntimicrobial activity
dc.subject.emtreeTetanus antibody
dc.subject.emtreeAntigen binding
dc.subject.emtreeTumor necrosis factor antibody animal
dc.subject.emtreeBacterial infection
dc.subject.emtreeRevie antibody production
dc.subject.emtreeHuman
dc.subject.emtreeDrug research
dc.subject.emtreeImmunotherapy
dc.subject.emtreeInfection
dc.subject.emtreeDrug use
dc.subject.emtreeInfection
dc.subject.emtreeKidney failure
dc.subject.emtreeNonhuman
dc.subject.meshAnimals
dc.subject.meshAntibodies, bacterial
dc.subject.meshAntibodies, monoclonal
dc.subject.meshVirus diseases
dc.subject.meshAntibodies, viral
dc.subject.meshInfection
dc.subject.meshBacterial infections
dc.subject.meshImmunotherapy
dc.subject.meshHumans
dc.subject.meshAnimal
dc.subject.meshBacterial infections
dc.subject.meshHuman
dc.subject.meshImmunotherapy
dc.subject.meshVirus diseases
dc.subject.scopusRespiratory Distress Syndrome, Adult; Allied Health Personnel; Disaster Disaster
dc.subject.wosBiochemistry & molecular biology
dc.subject.wosBiotechnology & applied microbiology
dc.titleBack to the future: Antibody-based strategies for the treatment of infectious diseases
dc.typeReview
dc.wos.quartileQ3 (Biotechnology & applied microbiology)
dc.wos.quartileQ4 (Biochemistry & molecular biology)
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/İmmunoloji Ana Bilim Dalı/Mikrobiyoloji Bölümü
local.indexed.atPubMed
local.indexed.atScopus

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

İndeksli Yayınlar / Indexed Publications